A detailed history of Cwm, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Cwm, LLC holds 2,156 shares of NVCR stock, worth $36,846. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,156
Previous 5,281 59.17%
Holding current value
$36,846
Previous $90,000 62.22%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$15.61 - $23.34 $48,781 - $72,937
-3,125 Reduced 59.17%
2,156 $34,000
Q2 2024

Jul 09, 2024

BUY
$11.83 - $24.05 $40,340 - $82,010
3,410 Added 182.26%
5,281 $90,000
Q1 2024

Apr 05, 2024

BUY
$12.42 - $17.29 $1,440 - $2,005
116 Added 6.61%
1,871 $29,000
Q4 2023

Feb 01, 2024

SELL
$11.13 - $15.78 $23,773 - $33,706
-2,136 Reduced 54.9%
1,755 $26,000
Q3 2023

Oct 11, 2023

BUY
$16.15 - $42.35 $35,271 - $92,492
2,184 Added 127.94%
3,891 $63,000
Q2 2023

Aug 03, 2023

SELL
$40.29 - $82.51 $13,859 - $28,383
-344 Reduced 16.77%
1,707 $71,000
Q1 2023

Apr 28, 2023

SELL
$56.44 - $118.81 $1,580 - $3,326
-28 Reduced 1.35%
2,051 $123,000
Q4 2022

Feb 01, 2023

BUY
$63.98 - $85.37 $15,227 - $20,318
238 Added 12.93%
2,079 $152,000
Q3 2022

Oct 27, 2022

BUY
$67.99 - $89.57 $6,255 - $8,240
92 Added 5.26%
1,841 $140,000
Q2 2022

Jul 28, 2022

BUY
$56.6 - $89.9 $7,527 - $11,956
133 Added 8.23%
1,749 $122,000
Q1 2022

Apr 21, 2022

BUY
$60.15 - $84.52 $22,917 - $32,202
381 Added 30.85%
1,616 $134,000
Q4 2021

Jan 31, 2022

SELL
$75.08 - $121.99 $10,961 - $17,810
-146 Reduced 10.57%
1,235 $93,000
Q1 2021

Sep 15, 2021

BUY
$124.11 - $190.17 $2,109 - $3,232
17 Added 1.25%
1,381 $306,000
Q1 2021

Apr 27, 2021

SELL
$124.11 - $190.17 $2,109 - $3,232
-17 Reduced 1.23%
1,364 $180,000
Q4 2020

Sep 15, 2021

BUY
$112.16 - $174.14 $8,412 - $13,060
75 Added 5.74%
1,381 $306,000
Q4 2020

Jan 27, 2021

SELL
$112.16 - $174.14 $8,412 - $13,060
-75 Reduced 5.43%
1,306 $226,000
Q3 2020

Sep 15, 2021

BUY
$58.05 - $111.31 $7,256 - $13,913
125 Added 9.95%
1,381 $306,000
Q3 2020

Oct 19, 2020

SELL
$58.05 - $111.31 $7,256 - $13,913
-125 Reduced 9.05%
1,256 $140,000
Q2 2020

Sep 15, 2021

SELL
$57.2 - $74.41 $138,824 - $180,593
-2,427 Reduced 63.73%
1,381 $306,000
Q2 2020

Jul 22, 2020

BUY
$57.2 - $74.41 $138,824 - $180,593
2,427 Added 175.74%
3,808 $226,000
Q1 2020

Sep 15, 2021

SELL
$57.05 - $95.75 $138,460 - $232,385
-2,427 Reduced 63.73%
1,381 $306,000
Q1 2020

Apr 28, 2020

BUY
$57.05 - $95.75 $138,460 - $232,385
2,427 Added 175.74%
3,808 $256,000
Q4 2019

Sep 14, 2021

SELL
$68.3 - $93.8 $165,764 - $227,652
-2,427 Reduced 63.73%
1,381 $306,000
Q4 2019

Jan 27, 2020

BUY
$68.3 - $93.8 $165,764 - $227,652
2,427 Added 175.74%
3,808 $321,000
Q3 2019

Sep 14, 2021

BUY
$61.86 - $97.8 $83,820 - $132,519
1,355 Added 5211.54%
1,381 $306,000
Q3 2019

Oct 22, 2019

SELL
$61.86 - $97.8 $83,820 - $132,519
-1,355 Reduced 98.12%
26 $2,000
Q2 2019

Sep 14, 2021

BUY
$42.22 - $63.23 $58,305 - $87,320
1,381 New
1,381 $306,000
Q2 2019

Jul 31, 2019

SELL
$42.22 - $63.23 $58,305 - $87,320
-1,381 Closed
0 $0
Q1 2019

Sep 02, 2021

SELL
$31.96 - $56.12 $122,055 - $214,322
-3,819 Reduced 73.44%
1,381 $0
Q2 2018

Jul 31, 2018

BUY
$19.85 - $32.0 $103,220 - $166,400
5,200 New
5,200 $163,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.79B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.